HCEMM / Hungarian Centre of Excellence for Molecular Medicine
Christoph W. Sensen is a prominent figure in the field of molecular medicine and biotechnology, currently serving as the Director General and Chief Executive Officer at the Hungarian Centre of Excellence for Molecular Medicine since December 2020. Previously, Sensen held various significant academic positions at Graz University of Technology from September 2014 to September 2022, including Universitätsprofessor and Head of the Institute of Computational Biotechnology. Additionally, Sensen was the Chief Scientific Officer at CNA Diagnostics Inc. from July 2010 to November 2020 and served as a Full Professor at the University of Calgary's Faculty of Medicine from February 2001 to August 2014. Early career experience includes roles at the National Research Council Canada and EMBL, contributing to marine biosciences and yeast genome sequencing. Sensen earned a Dr. rer. nat. in Biology from the University of Cologne and holds degrees from the University of Düsseldorf and Johannes Gutenberg University Mainz.
This person is not in any teams
HCEMM / Hungarian Centre of Excellence for Molecular Medicine
The Hungarian Centre of Excellence for Molecular Medicine – HCEMM - is a gamechanger organization which catalyzes reforming changes in the research culture and makes an impact in the regional development of Hungarian knowledge regions. The organisational and management model ensures autonomy and scientific excellence with an international evaluation system. Research groups are pursuing in cross-cutting fields and are reviewed every 5 years in order to ensure scientific excellence. HCEMM focuses on and supports molecular medicine-oriented research activities targeting key, highly prevalent ageing-related non-communicable diseases. HCEMM was created by the union of the University of Szeged, the Semmelweis University and the Biological Research Center of the Hungarian Academy of Sciences. They were joined by the National Research, Innovation and Development Office representing the Hungarian Government as project coordinator and by the European Molecular Biology Laboratory (EMBL) as an advanced scientific institution. Supported by EU Programme: H2020-EU.4.a. - Teaming of excellent research institutions and low performing RDI regions. Project starting date was 1 April 2017.